XML 31 R15.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Note 10 - Derivative Instruments | 12 Months Ended
--- | ---
Dec. 30, 2018
Notes to Financial Statements |
Derivative Instruments and Hedging Activities Disclosure [Text Block] | NOTE 10 – DERIVATIVE INST R UMENTS Interest Rate Risk Management In the third quarter of 2017, the Company entered into an interest rate swap transaction to fix the variable interest rate on a portion of its term loan borrowing in order to manage a portion of its exposure to interest rate fluctuations. The Company’s objective and strategy with respect to this interest rate swap is to protect the Company against adverse fluctuations in interest rates by reducing its exposure to variability to cash flows relating to interest payments on a portion of its outstanding debt. The Company is meeting its objective by hedging the risk of changes in its cash flows (interest payments) attributable to changes in LIBOR, the designated benchmark interest rate being hedged (the “hedged risk”), on an amount of the Company’s debt principal equal to the outstanding swap notional amount. Cash Flow Interest Rate Swap The Company’s interest rate swap is designated and qualifies as a cash flow hedge of forecasted interest payments. The Company reports the effective portion of the fair value gain or loss on the swap as a component of other comprehensive income (or other comprehensive loss). Gains or losses (if any) on any ineffective portion of derivative instruments in cash flow hedging relationships are recorded in the period in which they occur as a component of other expense (or other income) in the Consolidated Statement of Operations and as a component of operating activities in the Consolidated Statement of Cash Flows. The aggregate notional amount of the swap as of December 30, 2018 was $100 million. Forward Contracts The recently acquired nora operations are party to currency forward contracts designed to hedge the cash flow risk of intercompany sales from the manufacturing facility in Europe to the Americas. The Company’s objective and strategy with respect to these currency forward contracts is to protect the Company against adverse fluctuations in currency rates by reducing its exposure to variability in cash flows related to receipt of payment on intercompany sales. The Company is meeting its objective by hedging the risk of changes in its cash flows (intercompany payments for inventory) attributable to changes in the U.S. dollar/Euro exchange rate (the “hedged risk”). Changes in fair value attributable to components other than exchange rates will be excluded from the assessment of effectiveness and amortized to earnings on a straight-line basis. Changes in fair value related to the effective portion of these contracts will be reflected as a component of other comprehensive income (or other comprehensive loss). A portion of these forward contracts expire each month, with the final contract expiring in September of 2019. These contracts cover approximately 70% of the expected intercompany sales activity between the nora European manufacturing facility and the U.S. subsidiary and at this time the Company believes these are probable transactions given historical performance as well as budget projections. As of December 30, 2018, the notional value of these forward currency contracts and the future intercompany sales these instruments hedge was approximately $36 million. The table below sets forth the fair value of derivative instruments as of December 30, 2018 ( in thousands):
| Asset Derivatives as of |  | Liability Derivatives as of |
| Decem ber 30, 2018 |  | Dece mber 30, 2018 |
| Balance Sheet |  |  |  |  | Balance Sheet |  |  |
| Location |  | Fair Value |  | Location |  | Fair Value |
Derivative instruments designated as hedging instruments: |  |  |  |  |  |  |  |  |  |
Foreign currency contracts | Other current assets |  | $ | 651 |  | Other current liabilities |  |  | -- |
Interest rate swap contract | Other current assets |  |  | 1,794 |  | Other current liabilities |  |  | -- |
|  |  | $ | 2,445 |  |  |  |  | -- |
The table below sets forth the fair value of derivative instruments as of December 31, 2017 ( in thousands):
| Asset Derivatives as of |  | Liability Derivatives as of |
| December 31, 2017 |  | December 31, 2017 |
| Balance Sheet |  |  |  |  | Balance Sheet |  |  |
| Location |  | Fair Value |  | Location |  | Fair Value |
Derivative instruments designated as hedging instruments: |  |  |  |  |  |  |  |  |  |
Interest rate swap contract | Other current assets |  | $ | 904 |  | Other current liabilities |  |  | -- |
There was no significant impact to earnings from the changes in fair value of derivatives designated as cash flow hedges or from amounts excluded from the assessment of hedge effectiveness during 2018. There was no significant impact from the reclassification of hedged items from accumulated other comprehensive income during 2018. The amount of hedged items expected to be reclassified from accumulated other comprehensive income in the next 12 months is approximately $0.6 million. The following table summarizes the pre-tax impact that changes in the fair value of derivatives designated as cash flow hedges and included in the assessment of hedge effectiveness had on accumulated other comprehensive income during 2018 (in thousands):
|  | Gain (Loss) Recognized in Accumulated |
2018 |  | Other Comprehensive Income |
Foreign currency contracts |  | $ | (468 | )
Interest rate swap contract |  | $ | 890 |

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration